150 related articles for article (PubMed ID: 2992780)
1. Immune reactivity to Thomsen-Friedenreich antigen in patients with lung cancer detected by superoxide assay-leukocyte adherence inhibition test.
Ichinose Y; Yagawa K; Kaku M; Hara N; Ohta M
Cancer Res; 1985 Sep; 45(9):4473-7. PubMed ID: 2992780
[TBL] [Abstract][Full Text] [Related]
2. Superoxide assay-leukocyte adherence inhibition test and a soluble factor which stimulates the adherence of macrophages.
Yagawa K; Kaku M; Manabe H; Yasumoto K; Mashiba H; Iribe H; Yamagata J; Takenaka K; Nomura Y
Cancer Res; 1980 Dec; 40(12):4791-5. PubMed ID: 6254653
[TBL] [Abstract][Full Text] [Related]
3. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
4. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
Tsang PH; Holland JF; Bekesi JG
J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
[TBL] [Abstract][Full Text] [Related]
5. Human lung carcinoma monoclonal antibody specific for the Thomsen-Friedenreich antigen.
Stein R; Chen S; Grossman W; Goldenberg DM
Cancer Res; 1989 Jan; 49(1):32-7. PubMed ID: 2461799
[TBL] [Abstract][Full Text] [Related]
6. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
Kotlar HK; Sanner T
J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
[TBL] [Abstract][Full Text] [Related]
7. Indirect leukocyte migration inhibition reactions to a 3-M KCl extract of lung adenocarcinoma by lung cancer patients.
Suslov I; McCoy JL; Herberman RB
J Natl Cancer Inst; 1981 Feb; 66(2):233-7. PubMed ID: 7005504
[TBL] [Abstract][Full Text] [Related]
8. Humoral leukocyte adherence inhibition (H-LAI) test in screening of high risk group for lung cancer.
Kubasova T; Bank J; Köteles GJ; Horváth M
Neoplasma; 1990; 37(2):173-8. PubMed ID: 2188164
[TBL] [Abstract][Full Text] [Related]
9. [Thomsen antigen in human normal and tumor tissues].
Berdinskikh MS; Pavliuchenkova RP; Kiseleva AS; Kulakova AM; Kosiakov PN
Biull Eksp Biol Med; 1983 Mar; 95(3):59-61. PubMed ID: 6830988
[TBL] [Abstract][Full Text] [Related]
10. [Determination of antigen-dependent activity of human lung cancer transfer factor by H3-leucine leucine leukocyte adherence inhibition assay].
Xu WM
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):116-8. PubMed ID: 1377621
[TBL] [Abstract][Full Text] [Related]
11. [Natural killer activity and sensitization of the lymphocytes to tissue antigens in lung cancer].
Red'ko AA; Malygin AM; Dvaladze NA; Pleskach VA; Kutushev FKh
Vestn Khir Im I I Grek; 1988 Feb; 140(2):12-5. PubMed ID: 3388698
[TBL] [Abstract][Full Text] [Related]
12. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
[TBL] [Abstract][Full Text] [Related]
13. Differentiation-related expression of the Thomsen-Friedenreich glycotope in developing human lung and in lung carcinoma: lack of association with malignancy.
Toma V; Sata T; Vogt P; Komminoth P; Heitz PU; Roth J
Cancer; 1999 May; 85(10):2151-9. PubMed ID: 10326693
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of the Thomsen-Friedenreich antigen.
MacLean GD; Longenecker BM
Semin Cancer Biol; 1991 Dec; 2(6):433-9. PubMed ID: 1810470
[TBL] [Abstract][Full Text] [Related]
15. An isolated enriched organ-specific cancer neoantigen of human lung cancer for leukocyte adherence inhibition assays.
Dubois AE; Thomson DM; Sutherland ME; Scanzano R
Cancer Res; 1985 Jun; 45(6):2661-9. PubMed ID: 3886136
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
Grosser N; Thomson DM
Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients.
Bernhard MI; Wanebo HJ; Helm J; Pace RC; Kaiser DL
Cancer Res; 1983 Apr; 43(4):1932-7. PubMed ID: 6299532
[No Abstract] [Full Text] [Related]
18. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
[TBL] [Abstract][Full Text] [Related]
19. Early detection of breast cancer by leukocyte adherence inhibition assay.
Sanner T; Kotlar HK; Eker P; Brennhovd I; Host H; Jorgensen O
Cancer Detect Prev; 1983; 6(4-5):443-50. PubMed ID: 6360351
[TBL] [Abstract][Full Text] [Related]
20. A computerized tube leukocyte adherence inhibition assay in the diagnosis of human lung cancer.
Fink A; Eliraz A; Bruderman I; Wishnitzer R; Shindler D; Shani A; Offer S; Harpaz N; Bentwich Z
Diagn Immunol; 1985; 3(4):171-6. PubMed ID: 2417775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
